AzTrials
AzTrials

DepressionNCT04915040

Management of Depression and Social Isolation in Older Adults With Dementia With Home-based Telehealth Delivered Behavioral Activation + Caregiver Facilitation.

A study testing Behavioral Activation for Depression in people with Depression, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the feasibility of using behavioral activation therapy with caregiver support delivered via telemedicine to older adults with depression and probable mild dementia. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Depression
What is being tested?
Behavioral Activation for Depression
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
1 siteUnited States
Study dates
1 Jul 2021to 19 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Participant Eligibility Criteria:
  • able to speak and understand English;
  • a diagnosis of mild dementia, as determined by a Clinical Dementia Rating interview Sum of Boxes (CDR-SB) score in the mild range as defined by a score of 4.5 - 9.0;
  • and able to provide informed consent.
  • Caregiver Eligibility Criteria.
  • Beck Depression Inventory (BDI) score below clinical cutoff for depression and able to provide informed consent.

Who cannot join

  • Participant exclusion criteria:
  • presence of suicidal ideation with clear intent,
  • concurrent enrollment in another clinical trial for depression,
  • substance use disorder.
  • Caregiver exclusion criteria:
  • Active psychosis or significant dementia at screening;
  • presence of suicidal ideation with clear intent.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Texas Health Science Center at Houston

    Houston, Texas, 77030

Other trials in United States

About this study

The purpose of this study is to evaluate the feasibility of using behavioral activation therapy with caregiver support delivered via telemedicine to older adults with depression and probable mild dementia.

Conditions
Depression
Being tested
Behavioral Activation for Depression
Keywords
social support, dementia, caregivers
Medical subject headings
Depression, Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral Activation for DepressionBehavioural

    Behavioral Activation (BA) is an effective treatment for depression, and its components may increase social connection. Generally, caregivers are with the older adult care recipient on a regular basis and may be able, with the correct training, to help enhance certain features of the Behavioral Activation treatment, even under pandemic restrictions on social contact. Therefore, we propose to (a) integrate \& (b) gather feasibility data for home-based Behavioral Activation + Caregiver

Study groups in NCT04915040
Study groupRoleWhat they receive
Behavioral Activation for DepressionExperimentalNot described
Receives: Behavioral: Behavioral Activation for Depression

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of recruitment as assessed by number of participants enrolled in the study

    Measured: Week 0

  2. Feasibility of retention as assessed by number of participants who complete at least 6 sessions

    Measured: Week 8

  3. Feasibility of data collection as assessed by percent of missing data

    Measured: Week 8

  4. Change in Depression as measured by the Geriatric Depression Scale

    15-item self-report for each construct (yes/no) . Score goes from 1 to 15, a higher number indicates presence of depression.

    Measured: Week 0, Week 4, Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2021
  2. Study start1 Jul 2021
  3. Primary completion19 Jul 2022
  4. Study completion19 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04915040
Sponsor's protocol ID
HSC-SPH-21-0272
Status last verified
Nov 2023
First submitted
31 May 2021
Last updated
30 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Activation for Depression in people with Depression, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of recruitment as assessed by number of participants enrolled in the study (time frame: Week 0). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in